
BiographyPlease see http://thadhanilab.partners.org/
Researchsee http://thadhanilab.partners.org/
Publicationssee http://thadhanilab.partners.org/
A novel therapy that reduces elevated blood levels of a potentially toxic protein in women with preeclampsia, a dangerous complication of pregnancy, may someday address the therapeutic dilemma posed by the condition – balancing life-threatening risks to the mother with the dangers that early delivery poses to an immature fetus.
Almost a year's treatment with a vitamin D compound did not alleviate key structural and functional cardiovascular abnormalities in patients with kidney disease and cardiac enlargement.
Phone: 617-724-1207
Fax: 617-726-2340